779331-07-6

Basic information

• Product Name: 2-chloro-1-iodo-4-(methylsulfonyl)benzene
• Synonyms: 2-chloro-1-iodo-4-(methylsulfonyl)benzene
• CAS NO: 779331-07-6
• Molecular Weight: 316.547
• Mol File: 779331-07-6.mol

Chemical Properties

• CAS DataBase Reference: 2-chloro-1-iodo-4-(methylsulfonyl)benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-1-iodo-4-(methylsulfonyl)benzene(779331-07-6)
• EPA Substance Registry System: 2-chloro-1-iodo-4-(methylsulfonyl)benzene(779331-07-6)

Safety Data

• Hazardous Substances Data: 779331-07-6(Hazardous Substances Data)

Upstream product

• 13244-35-4 2-chloro-4-(methylsulfonyl)aniline 
• 779331-06-5 2-chloro-1-iodo-4-(methylthio)benzene 

Relevant articles and documents

NAPHTHYLACETIC ACIDS

The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.

CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES

Several parasites responsible for mammalian diseases are dependent on cysteine protease for various life-cycle functions. Inhibition or decreasing function of these proteases can be useful in the treatment and/or prevention of these parasitic diseases including; toxoplasmosis, malaria, African trypanosomiasis, Chagas disease, leishmaniasis, schistosomiasis, amebiasis, giardiasis, clonorchiasis, opisthorchiasis, paragonimiasis, fasciolopsiasis, lymphatic filariasis, onchocerciasis, dracunculiasis, ascariasis, trichuriasis, strongyloidiasis, trichostrongyliasis, trichomoniasis or cestodiasis. Compounds of formula I of the invention are capable of treating and/or preventing the above-identified diseases:

NOVEL COMPOUNDS

The invention relates to substituted phenoxyacetic acids (I) as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation